当前位置: 首页 > 详情页

Blood NCAPH2 Methylation Is Associated With Hippocampal Volume in Subjective Cognitive Decline With Apolipoprotein E epsilon 4 Non-carriers

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China, [2]Department of Neurology, Zhejiang Taizhou Municipal Hospital, Taizhou, Zhejiang, China, [3]Department of Neurobiology, Xuanwu Hospital of Capital Medical University, Beijing, China, [4]Center of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, China, [5]National Clinical Research Center for Geriatric Disorders, Beijing, China
出处:
ISSN:

关键词: Alzheimer' s disease NCAPH2 methylation subjective cognitive decline SCD

摘要:
Objective: This study assessed the methylation of peripheral NCAPH2 in individuals with subjective cognitive decline (SCD), identified its correlation with the hippocampal volume, and explored whether the correlation is influenced by apolipoprotein E epsilon 4 (APOE epsilon 4) status. Methods: Cognitively normal controls (NCs, n = 56), individuals with SCD (n = 81), and patients with objective cognitive impairment (OCI, n = 51) were included from the Sino Longitudinal Study on Cognitive Decline (NCT03370744). All participants completed neuropsychological assessments, blood tests, and structural MRI. NCAPH2 methylation was compared according to the diagnostic and APOE epsilon 4 status. Partial correlation analysis was conducted to assess the correlations between the hippocampal volume, cognitive tests, and the NCAPH2 methylation levels. Results: Individuals with SCD and patients with OCI showed significantly lower levels of NCAPH2 methylation than NCs, which were independent of the APOE epsilon 4 status. The NCAPH2 methylation levels and the hippocampal volumes were positively correlated in the SCD APOE epsilon 4 non-carriers but not in the OCI group. No association was found between the NCAPH2 methylation levels and the cognitive function. Conclusion: Abnormal changes in blood NCAPH2 methylation were found to occur in SCD, indicating its potential to be used as a useful peripheral biomarker in the early stage of Alzheimer's disease screening.

基金:

基金编号: 2016YFC1306300 61633018 82020108013

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 2 区 医学
小类 | 2 区 老年医学 3 区 神经科学
最新[2023]版:
大类 | 2 区 医学
小类 | 3 区 老年医学 3 区 神经科学
JCR分区:
出版当年[2019]版:
Q1 GERIATRICS & GERONTOLOGY Q2 NEUROSCIENCES
最新[2023]版:
Q2 NEUROSCIENCES Q2 GERIATRICS & GERONTOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者机构: [1]Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China, [2]Department of Neurology, Zhejiang Taizhou Municipal Hospital, Taizhou, Zhejiang, China,
共同第一作者:
通讯作者:
通讯机构: [1]Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China, [4]Center of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, China, [5]National Clinical Research Center for Geriatric Disorders, Beijing, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16461 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院